ロード中...

Landmark Studies Impacting the Medical Management of Benign Prostatic Hyperplasia

The treatment of benign prostatic hyperplasia (BPH) has changed dramatically over the past 10 years. Phase 3 studies of the safety and effectiveness of α-blockers (eg, terazosin and doxazosin) and 5-α-reductase inhibitors (eg, finasteride) for the treatment of BPH began to appear in the literature i...

詳細記述

保存先:
書誌詳細
第一著者: Lepor, Herbert
フォーマット: Artigo
言語:Inglês
出版事項: MedReviews, LLC 2003
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC1502353/
https://ncbi.nlm.nih.gov/pubmed/16985962
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!